Meet our Portfolio Companies
Combining AI and wet lab biology to design de novo antibodies for challenging GPCR targets implicated in cancer and immune diseases.
Anti-infective discovery platform coupling cell imaging with machine learning analysis to identify new drug candidates and new mechanisms of action.
Natural language processing for complex, unstructured medical data to accelerate patient matching to clinical trials and enable real world data research.
Wearable device delivering AI-informed vibrational neurostimulation to sense & reduce tremors in real time for Parkinson’s & Essential Tremor patients.
Microphysiological systems combining organs-on-chips, multi-omic analysis, and AI-driven modeling to accelerate drug discovery and development.
AI-driven SaaS platform creating more targeted, impactful engagement between healthcare providers and pharma sales teams.
Precision diagnostics platform combining metabolomics with machine learning to predict biomarkers response that help optimize treatment outcomes.
AI-driven pathology analysis enabling research and assisting pathologists in making rapid and accurate diagnoses for every patient, every time.
ML-powered platform that predicts extended-release formulations for any drug, enabling generics manufacturers to get XR formulations to market.
Computer vision for bedside image-based navigation in minimally invasive surgery, enabling new treatments in neurological surgery and beyond.